Dianthus Therapeutics, Inc. (DNTH) stock
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$92.48+3.18 (+3.56%)
Close on Nov 12, 2026Market cap $5.17BP/E –Yield 0.00%
Dianthus Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Dianthus Therapeutics's operating margin for the twelve months ending Dec 31, 2025 was -8739.3%. For fiscal 2025 it was -8739.3%, against -1633.7% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8739.3% | −7105.6 |
| FY2024 | Dec 31, 2024 | -1633.7% | +70.9 |
| FY2023 | Dec 31, 2023 | -1704.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -24486.3% | −22079.3 |
| Q3 FY2025 | Sep 30, 2025 | -10173.7% | −8797.1 |
| Q2 FY2025 | Jun 30, 2025 | -18096.9% | −16905.1 |
| Q1 FY2025 | Mar 31, 2025 | -2852.7% | −811.1 |
| Q4 FY2024 | Dec 31, 2024 | -2406.9% | +428.1 |
| Q3 FY2024 | Sep 30, 2024 | -1376.6% | +328.9 |
| Q2 FY2024 | Jun 30, 2024 | -1191.8% | −488.2 |
| Q1 FY2024 | Mar 31, 2024 | -2041.6% | – |
| Q4 FY2023 | Dec 31, 2023 | -2835.0% | – |
| Q3 FY2023 | Sep 30, 2023 | -1705.5% | – |
| Q3 FY2022 | Sep 30, 2022 | -703.7% | – |
See a number that looks wrong?